Juan Lopez, DDS
Oral and Maxillofacial Surgery · Coral Springs, FLNPI 1447281720
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 44 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Biotissue Holdings Inc. at 36.9% of the total. Reporting peaked in 2024 at $1,555 and has fallen 53.6% since, to $722 in 2025.
Across 44 payments — averaging $81.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotissue Holdings Inc.$1K
- Stryker$989
- Keystone Dental Inc.$657
- Zimvie Inc.$427
- Ormco Corporation$108
- Straumann USA LLC$45
- plus $49 from 2 others
Across 3 payments — averaging $499.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$1K
What the payments were for
- Food & beverage$3,57799%
- Gifts$251%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotissue Holdings Inc. | 20 | $1,327 |
| Stryker | 8 | $989 |
| Keystone Dental Inc. | 2 | $657 |
| Zimvie Inc. | 9 | $427 |
| Ormco Corporation | 1 | $108 |
| Straumann USA LLC | 2 | $45 |
| Axogen | 1 | $33 |
| Dentsply Sirona Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,602 in reported general payments places this provider in the 85th percentile of 498 oral and maxillofacial surgery providers in Florida.
See all oral and maxillofacial surgery providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Chlorhexidine Gluconate | 81 | $349 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 17 | $122 |
| Clindamycin Hcl | 24 | $115 |
| Ibuprofen | 40 | $103 |
| Amoxicillin | 20 | $61 |
| Tizanidine Hcl | 16 | $54 |
Paid to pharmacies, not to this prescriber.
Other oral and maxillofacial surgery in Coral Springs
- Michael PikosPalm Harbor$3M
- Ramon RuizOrlando$846K
- Curtis SchalitDaytona Beach$333K
- Rui FernandesJacksonville$107K
- Tyler HolleyOrlando$55K
- Shaun YoungNew Port Richey$46K
- Eduardo NicolaievskyMiami Beach$45K
- Craig MischSarasota$43K
- Jose MonteroMiami$42K
- Ramzey TursunMiami$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.